Search details
1.
Association among Terminally Differentiated T Cells, Frailty, and Dependency in a Group of Cuban Centenarians.
Gerontology
; 69(3): 239-248, 2023.
Article
in English
| MEDLINE | ID: mdl-35728563
2.
Aging and chronic inflammation: highlights from a multidisciplinary workshop.
Immun Ageing
; 20(1): 25, 2023 Jun 08.
Article
in English
| MEDLINE | ID: mdl-37291596
3.
Immunosenescence and inflammatory markers in Cuban centenarians: implications for survival.
Aging Clin Exp Res
; 35(11): 2839-2842, 2023 Nov.
Article
in English
| MEDLINE | ID: mdl-37821691
4.
Associations among cytokines, EGF and lymphocyte subpopulations in patients diagnosed with advanced lung cancer.
Cancer Immunol Immunother
; 70(6): 1735-1743, 2021 Jun.
Article
in English
| MEDLINE | ID: mdl-33388995
5.
Identifying predictive biomarkers of CIMAvaxEGF success in non-small cell lung cancer patients.
BMC Cancer
; 20(1): 772, 2020 Aug 17.
Article
in English
| MEDLINE | ID: mdl-32807114
6.
Use of a Humanized Anti-CD6 Monoclonal Antibody (Itolizumab) in Elderly Patients with Moderate COVID-19.
Gerontology
; 66(6): 553-561, 2020.
Article
in English
| MEDLINE | ID: mdl-33105142
7.
An anti-CD6 monoclonal antibody (itolizumab) reduces circulating IL-6 in severe COVID-19 elderly patients.
Immun Ageing
; 17(1): 34, 2020 Nov 14.
Article
in English
| MEDLINE | ID: mdl-33292350
8.
Biomarkers related to immunosenescence: relationships with therapy and survival in lung cancer patients.
Cancer Immunol Immunother
; 65(1): 37-45, 2016 Jan.
Article
in English
| MEDLINE | ID: mdl-26589409
9.
Nimotuzumab Increases the Recovery Rate of Severe and Critical COVID-19 Patients: Evaluation in the Real-World Scenario.
Front Public Health
; 10: 948520, 2022.
Article
in English
| MEDLINE | ID: mdl-35937253
10.
Thymic Polypeptide Fraction Biomodulina T Decreases Exhausted and Terminally Differentiated EMRA T Cells in Advanced Lung Cancer Patients Treated With Platinum-Based Chemotherapy.
Front Oncol
; 12: 823287, 2022.
Article
in English
| MEDLINE | ID: mdl-35155258
11.
Immune, inflammatory and prothrombotic parameters in COVID-19 patients treated with an anti EGFR antibody.
Immunol Lett
; 251-252: 1-8, 2022 12.
Article
in English
| MEDLINE | ID: mdl-36174772
12.
Augmenting antibody response to EGF-depleting immunotherapy: Findings from a phase I trial of CIMAvax-EGF in combination with nivolumab in advanced stage NSCLC.
Front Oncol
; 12: 958043, 2022.
Article
in English
| MEDLINE | ID: mdl-35992783
13.
An anti-CD6 antibody for the treatment of COVID-19 patients with cytokine-release syndrome: report of three cases.
Immunotherapy
; 13(4): 289-295, 2021 03.
Article
in English
| MEDLINE | ID: mdl-33397150
14.
Treatment of COVID-19 patients with the anti-CD6 antibody itolizumab.
Clin Transl Immunology
; 9(11): e1218, 2020.
Article
in English
| MEDLINE | ID: mdl-33304584
15.
Biomodulina T partially restores immunosenescent CD4 and CD8 T cell compartments in the elderly.
Exp Gerontol
; 124: 110633, 2019 09.
Article
in English
| MEDLINE | ID: mdl-31207285
16.
CIMAvax-EGF: Toward long-term survival of advanced NSCLC.
Semin Oncol
; 45(1-2): 34-40, 2018 01.
Article
in English
| MEDLINE | ID: mdl-30318082
17.
CIMAvax-EGF: A New Therapeutic Vaccine for Advanced Non-Small Cell Lung Cancer Patients.
Front Immunol
; 8: 269, 2017.
Article
in English
| MEDLINE | ID: mdl-28348561
18.
T Cell Subpopulations in Healthy Elderly and Lung Cancer Patients: Insights from Cuban Studies.
Front Immunol
; 8: 146, 2017.
Article
in English
| MEDLINE | ID: mdl-28261208
Results
1 -
18
de 18
1
Next >
>>